Jeff Garro
Stock Analyst at Stephens & Co.
(1.84)
# 3,301
Out of 5,044 analysts
54
Total ratings
37.84%
Success rate
-7.8%
Average return
Main Sectors:
Stocks Rated by Jeff Garro
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRVA Privia Health Group | Reiterates: Overweight | $32 | $25.60 | +25.00% | 5 | Sep 24, 2025 | |
| EVH Evolent Health | Reiterates: Equal-Weight | $9 | $7.08 | +27.12% | 6 | Sep 24, 2025 | |
| PHR Phreesia | Reiterates: Overweight | $32 | $23.22 | +37.81% | 9 | Sep 3, 2025 | |
| SLP Simulations Plus | Maintains: Overweight | $28 → $20 | $17.79 | +12.42% | 2 | Jul 15, 2025 | |
| TBRG TruBridge | Reiterates: Equal-Weight | $28 | $19.49 | +43.66% | 3 | Apr 10, 2025 | |
| VEEV Veeva Systems | Reiterates: Overweight | $280 | $286.67 | -2.33% | 2 | Mar 6, 2025 | |
| HCAT Health Catalyst | Maintains: Equal-Weight | $7 → $5 | $3.34 | +49.70% | 4 | Mar 6, 2025 | |
| CERT Certara | Reiterates: Overweight | $17 | $11.58 | +46.80% | 5 | Feb 27, 2025 | |
| DH Definitive Healthcare | Initiates: Equal-Weight | $5 | $2.77 | +80.51% | 1 | Dec 20, 2024 | |
| DOCS Doximity | Initiates: Equal-Weight | $55 | $66.77 | -17.63% | 1 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $5.5 | $20.56 | -73.25% | 3 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $250 | $217.83 | +14.77% | 2 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $17 | $20.54 | -17.23% | 1 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $28 | $8.23 | +240.22% | 2 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $20 | $18.21 | +9.83% | 3 | Aug 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $5 → $3.9 | $4.82 | -19.09% | 2 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4 → $3 | $2.11 | +42.18% | 3 | May 6, 2022 |
Privia Health Group
Sep 24, 2025
Reiterates: Overweight
Price Target: $32
Current: $25.60
Upside: +25.00%
Evolent Health
Sep 24, 2025
Reiterates: Equal-Weight
Price Target: $9
Current: $7.08
Upside: +27.12%
Phreesia
Sep 3, 2025
Reiterates: Overweight
Price Target: $32
Current: $23.22
Upside: +37.81%
Simulations Plus
Jul 15, 2025
Maintains: Overweight
Price Target: $28 → $20
Current: $17.79
Upside: +12.42%
TruBridge
Apr 10, 2025
Reiterates: Equal-Weight
Price Target: $28
Current: $19.49
Upside: +43.66%
Veeva Systems
Mar 6, 2025
Reiterates: Overweight
Price Target: $280
Current: $286.67
Upside: -2.33%
Health Catalyst
Mar 6, 2025
Maintains: Equal-Weight
Price Target: $7 → $5
Current: $3.34
Upside: +49.70%
Certara
Feb 27, 2025
Reiterates: Overweight
Price Target: $17
Current: $11.58
Upside: +46.80%
Definitive Healthcare
Dec 20, 2024
Initiates: Equal-Weight
Price Target: $5
Current: $2.77
Upside: +80.51%
Doximity
Dec 20, 2024
Initiates: Equal-Weight
Price Target: $55
Current: $66.77
Upside: -17.63%
Dec 20, 2024
Initiates: Equal-Weight
Price Target: $5.5
Current: $20.56
Upside: -73.25%
Dec 20, 2024
Initiates: Overweight
Price Target: $250
Current: $217.83
Upside: +14.77%
Dec 9, 2024
Initiates: Buy
Price Target: $17
Current: $20.54
Upside: -17.23%
Jul 26, 2023
Reiterates: Equal-Weight
Price Target: $28
Current: $8.23
Upside: +240.22%
Aug 5, 2022
Maintains: Overweight
Price Target: $15 → $20
Current: $18.21
Upside: +9.83%
May 11, 2022
Maintains: Underweight
Price Target: $5 → $3.9
Current: $4.82
Upside: -19.09%
May 6, 2022
Maintains: Neutral
Price Target: $4 → $3
Current: $2.11
Upside: +42.18%